Protalix BioTherapeutics ...

2.29
0.06 (2.69%)
At close: Jan 28, 2025, 2:02 PM

Protalix BioTherapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019
License and Service Revenue 120.00K 3.65M 5.03M 3.78M 5.13M 3.43M 6.91M
License and Service Revenue Growth -96.71% -27.49% +33.10% -26.26% +49.45% -50.35% n/a
Product Revenue 17.84M n/a n/a n/a n/a n/a 3.53M
Product Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
Brazil Revenue 10.40M 9.45M 6.40M
Brazil Revenue Growth +10.04% +47.69% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 2.60M 3.48M 3.12M 4.14M 3.67M 4.03M 3.12M 3.10M 2.85M 2.61M 3.15M 3.47M 2.95M 3.17M 3.14M 2.95M 2.82M 2.19M 3.19M 3.01M 2.59M 2.07M 2.23M 3.62M 2.64M 2.16M 2.50M 3.34M 2.84M 2.81M 2.54M 3.14M 2.01M 2.21M 2.00M 1.02M 2.25M 2.09M 1.91M
Selling, General, and Administrative Revenue Growth -25.52% +11.85% -24.81% +12.89% -8.96% +29.41% +0.55% +8.78% +9.08% -17.22% -9.00% +17.33% -6.84% +1.05% +6.34% +4.79% +28.35% -31.16% +5.74% +16.51% +25.10% -7.26% -38.43% +37.30% +22.24% -13.61% -25.28% +17.88% +0.78% +10.92% -19.23% +55.96% -8.70% +10.58% +95.59% -54.75% +7.74% +9.36% n/a
Research and Development Revenue 3.00M 2.96M 2.89M 3.10M 3.67M 4.47M 5.85M 5.62M 7.39M 7.58M 8.77M 7.64M 7.28M 7.69M 7.12M 10.95M 7.69M 9.19M 10.34M 9.60M 10.00M 13.32M 11.70M 9.57M 10.07M 7.24M 6.44M 8.99M 6.39M 8.83M 4.63M 5.71M 5.06M 7.82M 6.03M 5.39M 4.05M 4.96M 5.63M
Research and Development Revenue Growth +1.25% +2.56% -6.93% -15.45% -18.01% -23.47% +4.09% -23.95% -2.55% -13.55% +14.74% +4.93% -5.29% +7.96% -34.98% +42.47% -16.31% -11.16% +7.76% -4.05% -24.94% +13.89% +22.17% -4.93% +39.08% +12.39% -28.33% +40.71% -27.61% +90.67% -18.90% +12.90% -35.34% +29.78% +11.82% +32.94% -18.24% -11.91% n/a
Sales and Marketing Revenue 17.84M n/a 3.68M 10.11M 10.17M 15.07M 5.07M 25.29M 8.81M 3.38M 9.03M n/a 4.51M 3.24M 4.51M n/a 3.30M 3.65M 5.03M 8.98M 5.13M 3.43M 3.53M 9.20M 663.00K 2.01M 4.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth n/a -100.00% -63.63% -0.58% -32.55% +197.57% -79.97% +187.02% +160.56% -62.54% n/a -100.00% +38.95% -28.11% n/a -100.00% -9.65% -27.49% -43.96% +75.15% +49.45% -2.83% -61.63% +1287.48% -66.95% -55.94% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a